Dr Gan Liangying
Chief physician of the Department of Nephrology, Peking University People’s Hospital, China

Clinical Application Value of NT-proBNP in Chronic Kidney Diseases Patients with Cardiovascular Diseases


  • CKD complicated with CVD, especially HF death, is the main cause of death in patients with chronic kidney disease.
  • NT-proBNP level stratification can effectively predict the risk of CKD complicated with HF, cardiovascular mortality and all-cause mortality in patients with CKD stage 1-5.
  • The eGFR factor needs to be balanced for risk prediction for CKD patients using stratification cut-off value of NT-proBNP level.
  • NT-proBNP level stratification can not only predict the degree of cardiac function impairment (volume load), but also predict the renal function.

Dr Gan Liangying shares on how to interpret NT-proBNP values in the cardiac health management of CKD patients with HF.

Updates from Leading Experts

STRONG-HF: Post-discharge Heart Failure Management and Implementation of GDMT Heart Failure Therapy

Prof Alexandre Mebazaa shares the key results and highlights from the STRONG-HF study that assessed the safety, tolerability of optimization of guideline directed medical therapy. [...]


CANVAS study: NT-proBNP and CVD risk reduction

Can you give us a short description of the CANVAS program? The CANVAS program was a set of two trials, whose goal was to evaluate the role of an SGLT2...

1 July 2021
Dr James L Januzzi